WMA Declaration of Helsinki – Ethical Principles f... ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Ask the Heart Doctor | Heart Valve Disease and Sur...
Drug candidate slows motor neuron disease progress...
A Professional Overview of Hypertension ...
Long-term physical activity protects against metabolic syndr...
January 17,2026
Controlling hypertension can reduce dementia risk—even when ...
January 16,2026
Assessing methods for improving access to trauma care for ki...
January 15,2026
Portable device could help scientists track Alzheimer's dise...
January 14,2026
Neurons use physical signals, not electricity, to stabilize ...
January 13,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Dr. Fauci among hundreds who've contract...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
Announcement of the 2025 Nobel Prize in ...
More News
Biomarkers reveal how patients with glaucoma may respond to treatment

Biomarkers reveal how patients with glaucoma may respond to treatment

byUniversity College LondonMitochondrial respiration in PBMCs. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03068-6Over 700,000 people in the UK have glaucoma and it is the
Ophthalmology July 17,2024
Biomarkers reveal how patients with glaucoma may respond to treatment

Biomarkers reveal how patients with glaucoma may respond to treatment

byUniversity College LondonMitochondrial respiration in PBMCs. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03068-6Over 700,000 people in the UK have glaucoma and it is the
Ophthalmology July 17,2024
Supplements found to slow disease progression during late stage of 'dry' age-related macular degeneration

Supplements found to slow disease progression during late stage of 'dry' age-related macular degeneration

byNational Eye InstituteAge-related macular degeneration affects the macula, the part of the retina that provides central vision. Credit: National Eye InstituteIn a new analysis of data, researc
Ophthalmology July 17,2024
Supplements found to slow disease progression during late stage of 'dry' age-related macular degeneration

Supplements found to slow disease progression during late stage of 'dry' age-related macular degeneration

byNational Eye InstituteAge-related macular degeneration affects the macula, the part of the retina that provides central vision. Credit: National Eye InstituteIn a new analysis of data, researc
Ophthalmology July 17,2024
Sleep expert explains why some people need multiple alarms to wake up

Sleep expert explains why some people need multiple alarms to wake up

Sleep expert explains why some people need multiple alarms to wake upby Hunter Boyce, The Atlanta Journal-ConstitutionCredit: Pixabay/CC0 Public DomainFor many people, the snooze alarm is a vital part
Family Medicine July 17,2024
Sleep expert explains why some people need multiple alarms to wake up

Sleep expert explains why some people need multiple alarms to wake up

Sleep expert explains why some people need multiple alarms to wake upby Hunter Boyce, The Atlanta Journal-ConstitutionCredit: Pixabay/CC0 Public DomainFor many people, the snooze alarm is a vital part
Family Medicine July 17,2024
Safety of generic Viagra, other drugs called into doubt after false data found by FDA

Safety of generic Viagra, other drugs called into doubt after false data found by FDA

by Anna Edney, Bloomberg NewsCredit: CC0 Public DomainGeneric versions of erectile dysfunction drugs Viagra and Cialis, among other medications, were allowed on the U.S. market using potentially probl
Family Medicine July 17,2024
Safety of generic Viagra, other drugs called into doubt after false data found by FDA

Safety of generic Viagra, other drugs called into doubt after false data found by FDA

by Anna Edney, Bloomberg NewsCredit: CC0 Public DomainGeneric versions of erectile dysfunction drugs Viagra and Cialis, among other medications, were allowed on the U.S. market using potentially probl
Family Medicine July 17,2024
Systemic sclerosis is on the rise in Quebec, especially in children, study finds

Systemic sclerosis is on the rise in Quebec, especially in children, study finds

by Claire Loewen,McGill UniversityAge-standardized incidence rates (ASIR) over time (1996–2019) for females, males, and both. The gray shading depicts the 95% confidence intervals for the annual
Neurology July 17,2024
Systemic sclerosis is on the rise in Quebec, especially in children, study finds

Systemic sclerosis is on the rise in Quebec, especially in children, study finds

by Claire Loewen,McGill UniversityAge-standardized incidence rates (ASIR) over time (1996–2019) for females, males, and both. The gray shading depicts the 95% confidence intervals for the annual
Neurology July 17,2024
Gene set identifies glioblastomas most vulnerable to promising therapeutic

Gene set identifies glioblastomas most vulnerable to promising therapeutic

by Becky Ham,Translational Genomics Research InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Researchers from TGen, part of City of Hope, and from the University of Califo
Oncology July 17,2024
Gene set identifies glioblastomas most vulnerable to promising therapeutic

Gene set identifies glioblastomas most vulnerable to promising therapeutic

by Becky Ham,Translational Genomics Research InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Researchers from TGen, part of City of Hope, and from the University of Califo
Oncology July 17,2024
Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

by Krista Conger,Stanford UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDCAR-T cell therapy, which
Oncology July 17,2024
Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

by Krista Conger,Stanford UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDCAR-T cell therapy, which
Oncology July 17,2024
International study uncovers a molecule that could alleviate stroke-related brain injury

International study uncovers a molecule that could alleviate stroke-related brain injury

byThe Hospital for Sick ChildrenCredit: CC0 Public DomainA newly developed molecule, LK-2, could inform new therapies for stroke-related brain injury, find scientists at The Hospital for Sick Ch
Neurology July 17,2024
International study uncovers a molecule that could alleviate stroke-related brain injury

International study uncovers a molecule that could alleviate stroke-related brain injury

byThe Hospital for Sick ChildrenCredit: CC0 Public DomainA newly developed molecule, LK-2, could inform new therapies for stroke-related brain injury, find scientists at The Hospital for Sick Ch
Neurology July 17,2024
Scientists demonstrate a combination treatment can increase human insulin-producing cells in vivo

Scientists demonstrate a combination treatment can increase human insulin-producing cells in vivo

byThe Mount Sinai HospitalCredit: CC0 Public DomainIn preclinical studies, a team of researchers from Mount Sinai Health System in New York City and City of Hope in Los Angeles report new findin
Diabetes & Endocrinology July 17,2024
Scientists demonstrate a combination treatment can increase human insulin-producing cells in vivo

Scientists demonstrate a combination treatment can increase human insulin-producing cells in vivo

byThe Mount Sinai HospitalCredit: CC0 Public DomainIn preclinical studies, a team of researchers from Mount Sinai Health System in New York City and City of Hope in Los Angeles report new findin
Diabetes & Endocrinology July 17,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... Health spending has been rising across rich countries with different systems ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com